The HBV basal core promoter mutation confers a replicative advantage and transcriptionally reprograms hepatocytes toward HCC subtypes
This study demonstrates that the Hepatitis B virus basal core promoter (BCP) mutation enhances viral replication and transcriptionally reprograms hepatocytes to activate cancer-related pathways, thereby defining a distinct molecular subtype of hepatocellular carcinoma.